发布求助
文献互助 智能选刊 最新文献

Advanced Therapeutics最新文献

筛选
英文 中文
Targeting Ferroptosis for Cancer Immunotherapy: Molecular Mechanisms, Immune Microenvironment Crosstalk, and Clinical Translation Prospects 针对铁下垂的癌症免疫治疗：分子机制、免疫微环境串扰和临床转化前景
IF 2.6 4区 医学
Advanced Therapeutics Pub Date : 2026-04-10 DOI: 10.1002/adtp.202500529
Jiamin Shi, Guoren Zhou
{"title":"Targeting Ferroptosis for Cancer Immunotherapy: Molecular Mechanisms, Immune Microenvironment Crosstalk, and Clinical Translation Prospects","authors":"Jiamin Shi,&nbsp;Guoren Zhou","doi":"10.1002/adtp.202500529","DOIUrl":"10.1002/adtp.202500529","url":null,"abstract":"<div>\u0000 \u0000 <p>Ferroptosis, a novel form of iron-dependent programmed cell death (PCD), has garnered extensive attention in the cancer research field in recent years. Through its unique iron-dependent regulatory mechanisms and dynamic crosstalk with the cancer immune microenvironment (CIME), ferroptosis has established a new research paradigm for cancer therapy. This review systematically clarifies the molecular mechanisms underlying ferroptosis, thoroughly explores its dual regulatory roles within the CIME, and elaborates on the reciprocal interactions between ferroptosis and immune cell functions. It also comprehensively discusses ferroptosis-based cancer immunotherapy strategies and their clinical translation prospects. By integrating the latest research advances, this work provides a theoretical foundation and practical guidance for the clinical application of ferroptosis in cancer immunotherapy.</p>\u0000 </div>","PeriodicalId":7284,"journal":{"name":"Advanced Therapeutics","volume":"9 4","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147686955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-Efficiency, Short-Pulse Electrothermal Cancer Therapy Utilizing Polyethylene Glycol (PEG-) Based Titanium Carbide (Ti3C2) MXene Nanomaterials 利用聚乙二醇（PEG-）基碳化钛（Ti3C2） MXene纳米材料的高效、短脉冲电热癌症治疗
IF 2.6 4区 医学
Advanced Therapeutics Pub Date : 2026-04-10 DOI: 10.1002/adtp.202500385
Welela M. Kedir, Lunna Li, Shao-Xiang Go, Natasa Bajalovic, Lianna D. Soriano, Desmond K. Loke
{"title":"High-Efficiency, Short-Pulse Electrothermal Cancer Therapy Utilizing Polyethylene Glycol (PEG-) Based Titanium Carbide (Ti3C2) MXene Nanomaterials","authors":"Welela M. Kedir,&nbsp;Lunna Li,&nbsp;Shao-Xiang Go,&nbsp;Natasa Bajalovic,&nbsp;Lianna D. Soriano,&nbsp;Desmond K. Loke","doi":"10.1002/adtp.202500385","DOIUrl":"10.1002/adtp.202500385","url":null,"abstract":"<div>\u0000 \u0000 <p>Thermal agents in cancer therapy have exhibited promising results in clinical investigations. Nevertheless, the rapid degradation of thermal agents limits the efficacy of thermal ablation, while thermal agents exhibiting higher thermal ablation capabilities degrade at a comparatively slower rate. Here, the current work has controlled the thermal character of PEG-based titanium carbide (Ti<sub>3</sub>C<sub>2</sub>) nanosheets, and developed an integrated platform for cancer therapy aimed at mitigating the limitations associated with thermal agents. The assembly of PEG onto Ti<sub>3</sub>C<sub>2</sub>, in conjunction with the substantial current flow along the Ti<sub>3</sub>C<sub>2</sub> nanosheets, improves thermal ablation through Joule heating mechanisms. The findings from degradation studies reveal that the Ti─O structural oxidation plays a significant role in facilitating the preservation of rapid degradation time. A relative cell viability of 49% was attained, alongside an input pulse length of 5 µs. The Ti<sub>3</sub>C<sub>2</sub> MXene nanosheets also facilitate the development of a sensitive and rapid sensor platform for the early detection of cancer cells. This investigation introduces an optimal thermal agent that addresses existing limitations and provides evidence of concept for Ti<sub>3</sub>C<sub>2</sub>-based materials in the context of highly efficient electrothermal cancer therapy.</p>\u0000 </div>","PeriodicalId":7284,"journal":{"name":"Advanced Therapeutics","volume":"9 4","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147686954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting Ferroptosis for Cancer Immunotherapy: Molecular Mechanisms, Immune Microenvironment Crosstalk, and Clinical Translation Prospects 针对铁下垂的癌症免疫治疗：分子机制、免疫微环境串扰和临床转化前景
IF 2.6 4区 医学
Advanced Therapeutics Pub Date : 2026-04-10 DOI: 10.1002/adtp.202500529
Jiamin Shi, Guoren Zhou
{"title":"Targeting Ferroptosis for Cancer Immunotherapy: Molecular Mechanisms, Immune Microenvironment Crosstalk, and Clinical Translation Prospects","authors":"Jiamin Shi,&nbsp;Guoren Zhou","doi":"10.1002/adtp.202500529","DOIUrl":"https://doi.org/10.1002/adtp.202500529","url":null,"abstract":"<div>\u0000 \u0000 <p>Ferroptosis, a novel form of iron-dependent programmed cell death (PCD), has garnered extensive attention in the cancer research field in recent years. Through its unique iron-dependent regulatory mechanisms and dynamic crosstalk with the cancer immune microenvironment (CIME), ferroptosis has established a new research paradigm for cancer therapy. This review systematically clarifies the molecular mechanisms underlying ferroptosis, thoroughly explores its dual regulatory roles within the CIME, and elaborates on the reciprocal interactions between ferroptosis and immune cell functions. It also comprehensively discusses ferroptosis-based cancer immunotherapy strategies and their clinical translation prospects. By integrating the latest research advances, this work provides a theoretical foundation and practical guidance for the clinical application of ferroptosis in cancer immunotherapy.</p>\u0000 </div>","PeriodicalId":7284,"journal":{"name":"Advanced Therapeutics","volume":"9 4","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147686984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-Efficiency, Short-Pulse Electrothermal Cancer Therapy Utilizing Polyethylene Glycol (PEG-) Based Titanium Carbide (Ti3C2) MXene Nanomaterials 利用聚乙二醇（PEG-）基碳化钛（Ti3C2） MXene纳米材料的高效、短脉冲电热癌症治疗
IF 2.6 4区 医学
Advanced Therapeutics Pub Date : 2026-04-10 DOI: 10.1002/adtp.202500385
Welela M. Kedir, Lunna Li, Shao-Xiang Go, Natasa Bajalovic, Lianna D. Soriano, Desmond K. Loke
{"title":"High-Efficiency, Short-Pulse Electrothermal Cancer Therapy Utilizing Polyethylene Glycol (PEG-) Based Titanium Carbide (Ti3C2) MXene Nanomaterials","authors":"Welela M. Kedir,&nbsp;Lunna Li,&nbsp;Shao-Xiang Go,&nbsp;Natasa Bajalovic,&nbsp;Lianna D. Soriano,&nbsp;Desmond K. Loke","doi":"10.1002/adtp.202500385","DOIUrl":"https://doi.org/10.1002/adtp.202500385","url":null,"abstract":"<div>\u0000 \u0000 <p>Thermal agents in cancer therapy have exhibited promising results in clinical investigations. Nevertheless, the rapid degradation of thermal agents limits the efficacy of thermal ablation, while thermal agents exhibiting higher thermal ablation capabilities degrade at a comparatively slower rate. Here, the current work has controlled the thermal character of PEG-based titanium carbide (Ti<sub>3</sub>C<sub>2</sub>) nanosheets, and developed an integrated platform for cancer therapy aimed at mitigating the limitations associated with thermal agents. The assembly of PEG onto Ti<sub>3</sub>C<sub>2</sub>, in conjunction with the substantial current flow along the Ti<sub>3</sub>C<sub>2</sub> nanosheets, improves thermal ablation through Joule heating mechanisms. The findings from degradation studies reveal that the Ti─O structural oxidation plays a significant role in facilitating the preservation of rapid degradation time. A relative cell viability of 49% was attained, alongside an input pulse length of 5 µs. The Ti<sub>3</sub>C<sub>2</sub> MXene nanosheets also facilitate the development of a sensitive and rapid sensor platform for the early detection of cancer cells. This investigation introduces an optimal thermal agent that addresses existing limitations and provides evidence of concept for Ti<sub>3</sub>C<sub>2</sub>-based materials in the context of highly efficient electrothermal cancer therapy.</p>\u0000 </div>","PeriodicalId":7284,"journal":{"name":"Advanced Therapeutics","volume":"9 4","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147686956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Light-Triggered Antibody-Photosensitizer Conjugates Disrupt P-Glycoprotein Function to Reverse Multidrug Resistance 光触发抗体-光敏剂偶联物破坏p糖蛋白功能以逆转多药耐药
IF 2.6 4区 医学
Advanced Therapeutics Pub Date : 2026-03-27 DOI: 10.1002/adtp.202500565
Kathryn L. McNaughton, Tanvi Kotta, Carla Arnau Del Valle, Kaitlyn A. Moore, Idrisa Rahman, Dana M. Roque, Huang-Chiao Huang
{"title":"Light-Triggered Antibody-Photosensitizer Conjugates Disrupt P-Glycoprotein Function to Reverse Multidrug Resistance","authors":"Kathryn L. McNaughton,&nbsp;Tanvi Kotta,&nbsp;Carla Arnau Del Valle,&nbsp;Kaitlyn A. Moore,&nbsp;Idrisa Rahman,&nbsp;Dana M. Roque,&nbsp;Huang-Chiao Huang","doi":"10.1002/adtp.202500565","DOIUrl":"10.1002/adtp.202500565","url":null,"abstract":"<p>Ovarian cancer is the deadliest gynecologic disease with a 5-year survival rate of ∼30% for advanced stages. A major cause of poor prognosis is the development of chemoresistance, which accounts for 90% of ovarian cancer deaths. A key mediator of this resistance is the expression of ATP-binding cassette (ABC) drug efflux transporters, particularly P-glycoprotein (P-gp, also known as ABCB1), which is upregulated in response to treatment and confers the development of multidrug resistance (MDR). Existing small molecule inhibitors of P-gp often lack cancer selectivity and are thus associated with normal tissue toxicity. Our team has previously demonstrated that photodynamic therapy (PDT), employing the FDA-approved benzoporphyrin derivative (BPD) photosensitizer, can effectively inhibit ABC transporters in cancer cells. PDT is a localized treatment that utilizes a photosensitizer, a light-activated drug, and light of a specific wavelength to generate cytotoxic reactive oxygen species. However, BPD alone lacks cancer selectivity, making it less suitable for addressing disseminated tumors, such as those found in advanced-stage ovarian cancer. To improve cancer selectivity, we conjugated BPD to an anti-epidermal growth factor receptor (EGFR)-targeting monoclonal antibody (cetuximab) to form a photoimmunoconjugate (PIC). We demonstrate that PIC evades and inhibits P-gp-mediated efflux in chemoresistant ovarian cancer cells. These findings highlight the role of PICs and the importance of understanding their interactions with ABC transporters in combating multidrug resistance in advanced-stage cancer.</p>","PeriodicalId":7284,"journal":{"name":"Advanced Therapeutics","volume":"9 4","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adtp.202500565","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147666222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Issue Information (Adv. Therap. 4/2026) 发布信息（ad . therapy . 4/2026）
IF 2.6 4区 医学
Advanced Therapeutics Pub Date : 2026-03-27 DOI: 10.1002/adtp.70141
{"title":"Issue Information (Adv. Therap. 4/2026)","authors":"","doi":"10.1002/adtp.70141","DOIUrl":"10.1002/adtp.70141","url":null,"abstract":"","PeriodicalId":7284,"journal":{"name":"Advanced Therapeutics","volume":"9 4","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adtp.70141","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147666331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Issue Information (Adv. Therap. 4/2026) 发布信息（ad . therapy . 4/2026）
IF 2.6 4区 医学
Advanced Therapeutics Pub Date : 2026-03-27 DOI: 10.1002/adtp.70141
{"title":"Issue Information (Adv. Therap. 4/2026)","authors":"","doi":"10.1002/adtp.70141","DOIUrl":"https://doi.org/10.1002/adtp.70141","url":null,"abstract":"","PeriodicalId":7284,"journal":{"name":"Advanced Therapeutics","volume":"9 4","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adtp.70141","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147666329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-Powered Electrical Stimulation Strategies for Bone Regeneration 骨再生的自供电电刺激策略
IF 2.6 4区 医学
Advanced Therapeutics Pub Date : 2026-03-20 DOI: 10.1002/adtp.202500551
Jing Zhang, Jiangchuan Yang, Ayijiamila Mohetaer, Xiajie Hu, Fuxiang Song
{"title":"Self-Powered Electrical Stimulation Strategies for Bone Regeneration","authors":"Jing Zhang,&nbsp;Jiangchuan Yang,&nbsp;Ayijiamila Mohetaer,&nbsp;Xiajie Hu,&nbsp;Fuxiang Song","doi":"10.1002/adtp.202500551","DOIUrl":"https://doi.org/10.1002/adtp.202500551","url":null,"abstract":"<div>\u0000 \u0000 <p>Endogenous bioelectric cues regulate bone growth, repair, and remodeling. Conventional electrical stimulation can accelerate healing but is limited by wired power delivery, bulky hardware, and imprecise dosing. Self-powered electrical stimulation converts mechanical, optical, thermal, magnetic, or biochemical energy into physiologically relevant electric fields and currents. Distinct from reviews that focus on a single modality or narrow device class, this review synthesizes materials, device architectures, and application considerations across piezoelectric and triboelectric nanogenerators, photoelectric platforms, magnetoelectric composites, thermoelectric systems, bioelectrets, and biofuel cells. It further summarizes how these systems modulate membrane potential and Ca<sup>2+</sup> signaling, activate osteogenic programs, and coordinate angiogenesis and immune regulation. Key barriers include charge or polarization retention in ionic media, durability of devices and packaging under cyclic loading, stable output under small strains and temperature gradients, manufacturability, and rigorous validation in large, load-bearing models; additional considerations include Magnetic Resonance Imaging compatibility and magnetic-field safety for magnetoelectric implants. To improve comparability, a minimum reporting set is emphasized to quantify in situ tissue–device interface dose (field, current, waveform, duty cycle) together with input energy and biological readouts. Future directions include materials-by-design, hybrid harvesters with integrated storage, closed-loop sensing and control, and patient-specific digital planning.</p>\u0000 </div>","PeriodicalId":7284,"journal":{"name":"Advanced Therapeutics","volume":"9 3","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147567215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-Powered Electrical Stimulation Strategies for Bone Regeneration 骨再生的自供电电刺激策略
IF 2.6 4区 医学
Advanced Therapeutics Pub Date : 2026-03-20 DOI: 10.1002/adtp.202500551
Jing Zhang, Jiangchuan Yang, Ayijiamila Mohetaer, Xiajie Hu, Fuxiang Song
{"title":"Self-Powered Electrical Stimulation Strategies for Bone Regeneration","authors":"Jing Zhang,&nbsp;Jiangchuan Yang,&nbsp;Ayijiamila Mohetaer,&nbsp;Xiajie Hu,&nbsp;Fuxiang Song","doi":"10.1002/adtp.202500551","DOIUrl":"https://doi.org/10.1002/adtp.202500551","url":null,"abstract":"<div>\u0000 \u0000 <p>Endogenous bioelectric cues regulate bone growth, repair, and remodeling. Conventional electrical stimulation can accelerate healing but is limited by wired power delivery, bulky hardware, and imprecise dosing. Self-powered electrical stimulation converts mechanical, optical, thermal, magnetic, or biochemical energy into physiologically relevant electric fields and currents. Distinct from reviews that focus on a single modality or narrow device class, this review synthesizes materials, device architectures, and application considerations across piezoelectric and triboelectric nanogenerators, photoelectric platforms, magnetoelectric composites, thermoelectric systems, bioelectrets, and biofuel cells. It further summarizes how these systems modulate membrane potential and Ca<sup>2+</sup> signaling, activate osteogenic programs, and coordinate angiogenesis and immune regulation. Key barriers include charge or polarization retention in ionic media, durability of devices and packaging under cyclic loading, stable output under small strains and temperature gradients, manufacturability, and rigorous validation in large, load-bearing models; additional considerations include Magnetic Resonance Imaging compatibility and magnetic-field safety for magnetoelectric implants. To improve comparability, a minimum reporting set is emphasized to quantify in situ tissue–device interface dose (field, current, waveform, duty cycle) together with input energy and biological readouts. Future directions include materials-by-design, hybrid harvesters with integrated storage, closed-loop sensing and control, and patient-specific digital planning.</p>\u0000 </div>","PeriodicalId":7284,"journal":{"name":"Advanced Therapeutics","volume":"9 3","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147567560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-Powered Electrical Stimulation Strategies for Bone Regeneration 骨再生的自供电电刺激策略
IF 2.6 4区 医学
Advanced Therapeutics Pub Date : 2026-03-20 DOI: 10.1002/adtp.202500551
Jing Zhang, Jiangchuan Yang, Ayijiamila Mohetaer, Xiajie Hu, Fuxiang Song
{"title":"Self-Powered Electrical Stimulation Strategies for Bone Regeneration","authors":"Jing Zhang,&nbsp;Jiangchuan Yang,&nbsp;Ayijiamila Mohetaer,&nbsp;Xiajie Hu,&nbsp;Fuxiang Song","doi":"10.1002/adtp.202500551","DOIUrl":"https://doi.org/10.1002/adtp.202500551","url":null,"abstract":"<div>\u0000 \u0000 <p>Endogenous bioelectric cues regulate bone growth, repair, and remodeling. Conventional electrical stimulation can accelerate healing but is limited by wired power delivery, bulky hardware, and imprecise dosing. Self-powered electrical stimulation converts mechanical, optical, thermal, magnetic, or biochemical energy into physiologically relevant electric fields and currents. Distinct from reviews that focus on a single modality or narrow device class, this review synthesizes materials, device architectures, and application considerations across piezoelectric and triboelectric nanogenerators, photoelectric platforms, magnetoelectric composites, thermoelectric systems, bioelectrets, and biofuel cells. It further summarizes how these systems modulate membrane potential and Ca<sup>2+</sup> signaling, activate osteogenic programs, and coordinate angiogenesis and immune regulation. Key barriers include charge or polarization retention in ionic media, durability of devices and packaging under cyclic loading, stable output under small strains and temperature gradients, manufacturability, and rigorous validation in large, load-bearing models; additional considerations include Magnetic Resonance Imaging compatibility and magnetic-field safety for magnetoelectric implants. To improve comparability, a minimum reporting set is emphasized to quantify in situ tissue–device interface dose (field, current, waveform, duty cycle) together with input energy and biological readouts. Future directions include materials-by-design, hybrid harvesters with integrated storage, closed-loop sensing and control, and patient-specific digital planning.</p>\u0000 </div>","PeriodicalId":7284,"journal":{"name":"Advanced Therapeutics","volume":"9 3","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147567559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书